Browse > Article

Colchicine Derivatives Allows Prolonged Survival of Cardiac Allograft in the Rat  

Kim Young-Hak (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University)
Lee Hyung-Chang (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University)
Chung Won-Sang (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University)
Kang Jung-Ho (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University)
Kim Hyuck (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University)
Chon Sun-Ho (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Kuri Hospital)
Shin Sung-Ho (Department of Thoracic and Cardiovascular Surgery, Asan Medicial Center, University of Ulsan)
Publication Information
Journal of Chest Surgery / v.38, no.9, 2005 , pp. 595-600 More about this Journal
Abstract
Background: Colchicine with its immunosupressive properties has been used with benefcial effects in autoimmune disease, such as Gout, etc. Whether colchicine, by virtue of the above property, could attenuate the process of cardiac allograft rejection in the rats is investigated in this report. Material and Method: We compared the untreated group (Control, n=6), Cyclosporin A group (10 mg/kg, daily, n=20), and Colchicine derivative group (Colchicine 40 ${\mu}g$/kg, n=20) of cardiac allografts in the rats. Result: In the untreated control group (n=6), all of 6 rats showed rejection within 3 weeks after cardiac allograft. In the cyclosporin A group (n=20), cyclosporin A (10 mg daily oral dose) was administered at a 10 mg daily oral dose and promoted long-term survival (over 100 days). The cyclosporin A group had one mortality at the 18th post-operative day due to infection. Furthermore, in the Colchicine derivatives group (n=20) with a daily IP (Intra Peritoneum) dose (40 ug/kg/day), we observed long-term survival.(> 100 days), except for one rat that died of an anesthetic problem (respiratory failure) at the 9th post-operative day. Conclusion: Experiments have also been performed to evaluate whether the effect of colchicine derivatives allowed prolonged survival of cardiac allografts compared with the cyclosporin A administration group in the rats.
Keywords
Allograft; Drugs; Immunosupression;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Osterman D, Perico N, Imbert O, Barbui C, Bontempelli M, Remuzzi G. Colchicine allows prolonged survival of highly reactive renal allograft in the rat. J Am Soc Nephrol 1993; 4:1294-9
2 Billingham ME. (Diagnosis of cardiac rejection by) The post-surgical heart. The pathology of cardiac transplantation. Am J Cardiovasc Pathol 1988;1:319-34   PUBMED
3 Morris RE, Wu J, Shorthouse R. A study of the contrastinf effects of cyclosporine, FK506, & rapamycin on suppression of allograft rejection. Transplant Proc 1990;9:1634-41
4 Lyons MJ, Amador R, Petito C, Nagashima K, Weinreb H, Zabriskie JB. Inhibition of acute experimental allergic encephalitis by colchicine. J Exp Med 1986;164:1803-7   DOI   ScienceOn
5 Lin HY, Rocher LL, Moquillan MA, Schmaltz S, Pallella TD, Fox IH. Cyclosporin-induced hyperuricemia and gout. New Engl J Med 1989;321:287-92   DOI   ScienceOn
6 Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Eightyear results of cyclosporin-treated patients with cardiac transplants. J Thorac Cardiovasc Surg 1999;99:500-9
7 Seidemann P, Fjellner B, Johannessen A. Psoriatic arthritis treated with oral colchicine. J Rheumatol 1987;14:777-9
8 Rosenthal AS, Shevach EM. Function of macrophages in antigen recognition by guinea pig T lymphocytes requirement for histocompatible macrophages and lymphocytes. J Exp Med 1973;138:1194-8   DOI   ScienceOn
9 Yussim A, Bar-Nathan N, Lustig S, et al. Gastro-intestinal hepatorenal and neuromuscular toxicity caused by cyclosporine- colchicine interaction in renal transplantation. Transplant Proc 1994;13:2825-6
10 Burke JF Jr, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal transplant recipients. N Engl J Med 1994;331:358-63   DOI   ScienceOn
11 Borisy GG, Taylor EW. The mechanism of action of colchicine- binding of colchine-3H to cellular protein. J Cell Biol 1967;34:533-48
12 Shumway SJ. Basic immunologic concepts involved in organ transplantation. In: Baumgartner WA, Reitz BA, Achoff SC. Heart & Heart-Lung transplantation. Philadelphia: WB Saunders. 1990;15-24
13 Young CJ, Sollinger HW. RS61443:A new Immunosuppressive Agent. Transplant Proc 1994;13:3144-6
14 Freed BM, Lempert N, Lawrence DA, et al. The inhibitory effects of N-ethylmaleimide, colchicine and cytocholasins on human T-cell functions. Int J Immunophamacol 1989;11:459- 65   DOI   ScienceOn
15 Rosenman SJ, Ganji AA, Gallatin WM. Contact dependent redistribution of cell surface adhesion and activation molecules reorganization. FASEB J 1991;5:603
16 Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-9
17 Kormos RL, Glassman LR, Pham SM, et al. Long-term outcome in a randomized trial of rabbit antithymocyte globulin vs OKT3 immunoprophylaxis. J Heart Lung Transplant 1994;13:S42
18 Meiser BM, Reichant B. New trends in clinical Immunosuppression. Transplant Proc 1994;13:3181-3